The contradicting reports about efficiency and safety of TNF-α blockers in animal models and patients with severe asthma (27, 28) prompted us to study the effect of TNF-α neutralization during pulmonary infection and exacerbation of AAI. This evidence concerns the gene TNF and asthma.